|
|
Volumn 2, Issue 7, 2006, Pages 432-435
|
|
Position statement regarding usage of biosimilars. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique;Règles d'utilisation des biosimilaires. Propositions consensuelles de la Société de néphrologie, de la Société francophone de dialyse et de la Société de néphrologie pédiatrique
a
a
NONE
|
|
Author keywords
Biosimilars; Epoetin; Guidelines
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
BLOOD DERIVATIVE;
GENERIC DRUG;
RECOMBINANT ERYTHROPOIETIN;
BIOEQUIVALENCE;
BIOTECHNOLOGY;
BLOOD STORAGE;
CLINICAL RESEARCH;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG LABELING;
DRUG RESEARCH;
DRUG SURVEILLANCE PROGRAM;
DRUG USE;
HUMAN;
MEDICAL SOCIETY;
PATENT;
POSTMARKETING SURVEILLANCE;
SHORT SURVEY;
UNSPECIFIED SIDE EFFECT;
BIOLOGICAL PRODUCTS;
EPOETIN ALFA;
GUIDELINES;
HUMANS;
THERAPEUTIC EQUIVALENCY;
|
|
EID: 33845539688
PISSN: 17697255
EISSN: None
Source Type: Journal
DOI: 10.1016/j.nephro.2006.06.008 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
